IT1114247B - Componente di dosaggio farmaceutico a emissione controllata - Google Patents

Componente di dosaggio farmaceutico a emissione controllata

Info

Publication number
IT1114247B
IT1114247B IT7922743A IT2274379A IT1114247B IT 1114247 B IT1114247 B IT 1114247B IT 7922743 A IT7922743 A IT 7922743A IT 2274379 A IT2274379 A IT 2274379A IT 1114247 B IT1114247 B IT 1114247B
Authority
IT
Italy
Prior art keywords
pharmaceutical dosage
dosage component
controlled emission
emission
controlled
Prior art date
Application number
IT7922743A
Other languages
English (en)
Other versions
IT7922743A0 (it
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of IT7922743A0 publication Critical patent/IT7922743A0/it
Application granted granted Critical
Publication of IT1114247B publication Critical patent/IT1114247B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT7922743A 1978-05-18 1979-05-17 Componente di dosaggio farmaceutico a emissione controllata IT1114247B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/907,036 US4153677A (en) 1978-05-18 1978-05-18 Controlled-release composition

Publications (2)

Publication Number Publication Date
IT7922743A0 IT7922743A0 (it) 1979-05-17
IT1114247B true IT1114247B (it) 1986-01-27

Family

ID=25423420

Family Applications (1)

Application Number Title Priority Date Filing Date
IT7922743A IT1114247B (it) 1978-05-18 1979-05-17 Componente di dosaggio farmaceutico a emissione controllata

Country Status (15)

Country Link
US (1) US4153677A (it)
JP (1) JPS54160712A (it)
AU (1) AU525125B2 (it)
BE (1) BE876306A (it)
CA (1) CA1123737A (it)
CH (1) CH640133A5 (it)
DE (1) DE2920254A1 (it)
DK (1) DK203879A (it)
FR (1) FR2425853A1 (it)
GB (1) GB2020973B (it)
IT (1) IT1114247B (it)
LU (1) LU81293A1 (it)
NL (1) NL7903725A (it)
NZ (1) NZ190394A (it)
SE (1) SE7904353L (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209223A (en) * 1981-06-19 1982-12-22 Tanabe Seiyaku Co Ltd Microcapsule for intracranial anti hypotension and its production
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US4847302A (en) * 1984-06-04 1989-07-11 Merck & Co., Inc. Use of certain compounds in livestock food as growth promotants for better feed utilization and improved carcass composition
IT1176853B (it) * 1984-10-02 1987-08-18 Eurand Spa Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
CA1266235A (en) * 1985-03-25 1990-02-27 Wallace E. Becker Tablet composition for drug combinations
US4761421A (en) * 1985-05-08 1988-08-02 Merck & Co., Inc. Use of certain compounds in livestock food as growth promotants for better feed utilization and improved carcass composition
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
US6812233B1 (en) * 1991-03-06 2004-11-02 Emory University Therapeutic nucleosides
CA2067975C (en) * 1991-05-20 2003-01-14 Cynthia M. Blase Buffered matrix aspirin tablet
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
DK1711169T3 (da) * 2004-02-04 2007-09-17 Alembic Ltd Coatede mikrodepottabletter med venlafaxinhydrochlorid

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3400185A (en) * 1965-04-08 1968-09-03 Bristol Myers Co Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof
FR5788M (it) * 1965-11-18 1968-03-18
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
US3904671A (en) * 1969-04-01 1975-09-09 Sterling Drug Inc Esters of 3-(hydroxy or hydroxymethyl)-4-hydroxyphenyl aminomethyl ketones
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US3632739A (en) * 1969-12-29 1972-01-04 Sandoz Ag Solid sustained release pharmaceutical preparation
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition

Also Published As

Publication number Publication date
SE7904353L (sv) 1979-11-19
CA1123737A (en) 1982-05-18
DK203879A (da) 1979-11-19
GB2020973A (en) 1979-11-28
JPS54160712A (en) 1979-12-19
CH640133A5 (fr) 1983-12-30
BE876306A (fr) 1979-11-19
AU525125B2 (en) 1982-10-21
US4153677A (en) 1979-05-08
FR2425853A1 (fr) 1979-12-14
IT7922743A0 (it) 1979-05-17
GB2020973B (en) 1982-12-15
NL7903725A (nl) 1979-11-20
DE2920254A1 (de) 1979-11-22
NZ190394A (en) 1980-11-28
LU81293A1 (fr) 1979-12-07
AU4695879A (en) 1979-11-22

Similar Documents

Publication Publication Date Title
SE7803527L (sv) Lekemedelsdosenhet
BE879918A (fr) Distributeur de medicament
AU513845B2 (en) Pharmaceutical dosage forms
SE7805954L (sv) Terapeutiska medel
SE7709359L (sv) Farmaceutisk doseringsform
DK153631C (da) Medikamentdispenser
AU521053B2 (en) Medicament dosage form
SE433071B (sv) Doseringsbehallare for medicinska preparat
NL190664B (nl) Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten.
PT73686A (pt) Pharmaceutical formulation
DK572878A (da) Sproejte navnlig injektionssproejte
DK22978A (da) Laegemiddelsproejte
BE871584A (fr) Preparations pharmaceutiques
IT1114247B (it) Componente di dosaggio farmaceutico a emissione controllata
FI790039A7 (fi) Laekemedelssprayanordning
IT1107773B (it) Composti organici per uso farmaceutico
GB2013084B (en) Ophthalmic drug dosage
BE864359A (fr) Compositions pharmaceutiques antioestrogenes
AU504182B2 (en) Pharmaceutical dosage forms
NL7711446A (nl) Pharmaceutische desinfecterend preparaat.
SE7809887L (sv) Terapeutiska medel
BE865710A (fr) Medicament contre les diarrhees
FI783049A7 (fi) Farmaceutiskt aktiva(omega-aminoalkoxi)dibenzyler
RO76074A2 (ro) Medicament energizant
RO77521A2 (ro) Medicament antireumatic